Does fluvastatin improve arterial functions in dyslipidemic renal transplant recipients?

Simple item page
dc.contributor.authorEryılmaz, Salih
dc.contributor.authorYıldız, Abdülmecit
dc.contributor.buuauthorErsoy, Alparslan
dc.contributor.buuauthorErsoy, Canan
dc.contributor.buuauthorGül, Bülent Cuma
dc.contributor.buuauthorBaran, İbrahim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0710-0923tr_TR
dc.contributor.orcid0000-0003-2467-9356tr_TR
dc.contributor.researcheridAAH-5054-2021tr_TR
dc.contributor.researcheridAAH-8861-2021tr_TR
dc.contributor.researcheridA-7063-2018tr_TR
dc.contributor.scopusid35612977100
dc.contributor.scopusid6701485882
dc.contributor.scopusid56065997600
dc.contributor.scopusid35572557400
dc.date.accessioned2024-02-06T05:55:44Z
dc.date.available2024-02-06T05:55:44Z
dc.date.issued2013-11-23
dc.description.abstractRenal transplant recipients (RTRs) have increased cardiovascular (CV) risk. Arterial stiffness (AS) contributes to the occurrence of CV disease. We aimed to examine the effect of fluvastatin on CV risk factors and AS in RTRs. Fourteen dyslipidemic RTRs were enrolled. They received daily open-label 80 mg fluvastatin therapy for 6 months. Large (C1) and small (C2) vessel compliances of the radial artery were determined by pulse wave analysis at baseline and after 6 months of treatment with fluvastatin. No significant changes in C1 or C2 measurements were observed. Total cholesterol, LDL cholesterol, and triglyceride levels decreased significantly. Our results suggest that 6-month treatment with fluvastatin in dyslipidemic RTRs was not associated with improvement in AS despite significant improvement of lipid profile.en_US
dc.identifier.citationErsoy, A. vd. (2013). "Does fluvastatin improve arterial functions in dyslipidemic renal transplant recipients?". Biomedical Research-India, 25(2), 157-160.en_US
dc.identifier.eissn0976-1683
dc.identifier.endpage160tr_TR
dc.identifier.issn0970-938X
dc.identifier.issue2tr_TR
dc.identifier.startpage157tr_TR
dc.identifier.urihttps://hdl.handle.net/11452/39536en_US
dc.identifier.volume25tr_TR
dc.identifier.wos000342566500004tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherScientific Publishers Indiaen_US
dc.relation.collaborationSanayitr_TR
dc.relation.journalBiomedical Research-Indiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectArterial stiffnessen_US
dc.subjectResearch & experimental medicineen_US
dc.subjectStatinen_US
dc.subjectEngineeringen_US
dc.subjectRenal transplanten_US
dc.subjectTherapyen_US
dc.subjectDyslipidemiaen_US
dc.subjectAtorvastatinen_US
dc.subjectPulse-wave velocityen_US
dc.subjectDistensibilityen_US
dc.subjectCardiovascular-diseaseen_US
dc.subjectStatinsen_US
dc.subjectEndothelial functionen_US
dc.subjectStiffnessen_US
dc.subjectControlled-trialen_US
dc.subject.emtreeAzathioprineen_US
dc.subject.emtreeBeta adrenergic receptor blocking agenten_US
dc.subject.emtreeCalcium antagonisten_US
dc.subject.emtreeCyclosporin Aen_US
dc.subject.emtreeDipeptidyl carboxypeptidase inhibitoren_US
dc.subject.emtreeFluindostatinen_US
dc.subject.emtreeLow density lipoprotein cholesterolen_US
dc.subject.emtreeMycophenolic acid 2 morpholinoethyl esteren_US
dc.subject.emtreePrednisoloneen_US
dc.subject.emtreeTacrolimusen_US
dc.subject.emtreeThiazide diuretic agenten_US
dc.subject.emtreeTriacylglycerolen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArterial stiffnessen_US
dc.subject.emtreeArtery complianceen_US
dc.subject.emtreeArtery diseaseen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCardiovascular risken_US
dc.subject.emtreeCholesterol blood levelen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeDyslipidemiaen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGraft recipienten_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKidney graften_US
dc.subject.emtreeLipid analysisen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeOpen studyen_US
dc.subject.emtreePulse waveen_US
dc.subject.emtreeRadial arteryen_US
dc.subject.emtreeRisk assessmenten_US
dc.subject.emtreeTreatment durationen_US
dc.subject.emtreeTreatment responseen_US
dc.subject.emtreeTriacylglycerol blood levelen_US
dc.subject.emtreeYoung adulten_US
dc.subject.scopusPulse Wave Analysis; Arterial Stiffness; Blood Pressureen_US
dc.subject.wosEngineering, biomedicalen_US
dc.subject.wosMedicine, research & experimentalen_US
dc.titleDoes fluvastatin improve arterial functions in dyslipidemic renal transplant recipients?en_US
dc.typeArticleen_US
dc.wos.quartileQ4 (Medicine, research & experimental)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science